
Quick take: Psychedelic therapy for veterans just got friendly nods from both parties at a House hearing.
According to States Newsroom reporting, the House Veterans Affairs health subcommittee spent about two and a half hours on how the VA would offer these treatments if the FDA approves them. Republican chair Mariannette Miller-Meeks backed the idea. Meanwhile, Democrat Julia Brownley called the VA’s clinical trials welcome news.
What psychedelic therapy for veterans could look like
VA officials said just over 2 million veterans live with treatment-resistant depression. In fact, about 180,000 of them may qualify for psychedelic treatment. The VA also named 10 initial treatment sites and agreed to share the list within 30 days.
Trials are already running. For example, MDMA-assisted therapy studies began this year at VA facilities in Rhode Island and Connecticut. Also, reports say an April executive order told the FDA to work with the VA, DEA and HHS on clearing barriers.
However, nobody is handing out prescriptions yet. The treatments still need FDA approval, and the drugs under review remain Schedule I. Staff cuts also raise doubts about whether the VA can deliver. Most of the first sites sit on the coasts, and one lawmaker noted that none are in the Southeast.
Dosing sessions can last six to eight hours, so clinics need space and trained people. Brownley put it plainly, saying the treatments “will not be a panacea for everyone.” Therefore, expect a slow rollout, and expect plenty more hearings.
Still, we think anyone who served and still cannot sleep deserves real options. For once, the people writing the rules seem to be listening, and that alone is progress.
Why it matters to stoners: Every time a Schedule I substance gets a serious, bipartisan hearing, the old stigma loses a little more ground.
Also, see our post on the FDA and psychedelic research.
More on this topic: see our California psychedelics hub.
